These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6185600)
1. Dextran sulfate-dependent fibrinolysis in whole human plasma. Miles LA; Rothschild Z; Griffin JH J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600 [TBL] [Abstract][Full Text] [Related]
2. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate. Tsuda H; Miyata T; Iwanaga S; Yamamoto T Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792 [TBL] [Abstract][Full Text] [Related]
3. The contact activation mechanism in human plasma: activation induced by dextran sulfate. van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360 [TBL] [Abstract][Full Text] [Related]
4. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator. Jespersen J; Kluft C Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350 [TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis. Hauert J; Nicoloso G; Schleuning WD; Bachmann F; Schapira M Blood; 1989 Mar; 73(4):994-9. PubMed ID: 2465792 [TBL] [Abstract][Full Text] [Related]
6. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen. Mandle RJ; Kaplan AP Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876 [TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic studies in 13 unrelated families with factor XII deficiency. Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558 [TBL] [Abstract][Full Text] [Related]
9. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen. Gordon EM; Ratnoff OD; Goldsmith GH J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011 [TBL] [Abstract][Full Text] [Related]
10. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin. Espana F; Aznar J; Estelles A J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261 [TBL] [Abstract][Full Text] [Related]
12. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. Mandle R; Kaplan AP J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348 [TBL] [Abstract][Full Text] [Related]
13. Induction of fibrinolysis by polyanions in human plasma. Klauser RJ Thromb Haemost; 1988 Oct; 60(2):324-7. PubMed ID: 2464201 [TBL] [Abstract][Full Text] [Related]
14. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. Weiss AS; Gallin JI; Kaplan AP J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577 [TBL] [Abstract][Full Text] [Related]
15. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator. Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248 [TBL] [Abstract][Full Text] [Related]
16. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein. Binnema DJ; Dooijewaard G; Turion PN Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069 [TBL] [Abstract][Full Text] [Related]
17. Effects of dextran sulphate and flufenamic acid on euglobulin fibrinolytic activity of glass-treated or heated plasma. Jenks RL; Astrup T Haemostasis; 1980; 9(4):248-56. PubMed ID: 6156880 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of purified human alpha 2-antiplasmin and purified human C1 inhibitor by synthetic fibrinolytic agents. Miles LA; Burnier JP; Verlander MS; Goodman M; Kleiss AJ; Griffin JH Blood; 1981 Jun; 57(6):1015-24. PubMed ID: 6452920 [TBL] [Abstract][Full Text] [Related]
19. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. Scott CF; Silver LD; Schapira M; Colman RW J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202 [TBL] [Abstract][Full Text] [Related]
20. Activation of factor XII by dextran sulfate: the basis for an assay of factor XII. Tankersley DL; Alving BM; Finlayson JS Blood; 1983 Aug; 62(2):448-56. PubMed ID: 6191802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]